Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 13-Feb-2020
No. of pages: 107

Market Overview

The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9594.6 million by 2025, from USD 8567.7 million in 2019.

The Diagnostic Radiopharmaceuticals & Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Diagnostic Radiopharmaceuticals & Contrast Media market has been segmented into:

- Radiopharmaceuticals

- Contrast Media

By Application, Diagnostic Radiopharmaceuticals & Contrast Media has been segmented into:

- Diagnostic

- Therapeutic

- Ionizing Radiation based Radioimaging

- Non-Ionizing Radiation based Radioimaging

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Radiopharmaceuticals & Contrast Media market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Radiopharmaceuticals & Contrast Media markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Radiopharmaceuticals & Contrast Media market.

The report offers in-depth assessment of the growth and other aspects of the Diagnostic Radiopharmaceuticals & Contrast Media market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina, Colombia)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Diagnostic Radiopharmaceuticals & Contrast Media Market Share Analysis

Diagnostic Radiopharmaceuticals & Contrast Media competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Radiopharmaceuticals & Contrast Media sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Radiopharmaceuticals & Contrast Media sales, revenue and market share for each player covered in this report.

The major players covered in Diagnostic Radiopharmaceuticals & Contrast Media are:

Amag Pharmaceuticals

Mallinckrodt

Daiichi Sankyo

Bayer Healthcare

Lantheus

Bracco Imaging

Nordion

Guerbet

GE Healthcare

Medtronic

Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Classification of Diagnostic Radiopharmaceuticals & Contrast Media by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type in 2019
1.2.3 Radiopharmaceuticals
1.2.4 Contrast Media
1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Application
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic
1.3.3 Therapeutic
1.3.4 Ionizing Radiation based Radioimaging
1.3.5 Non-Ionizing Radiation based Radioimaging
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Regions
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnostic Radiopharmaceuticals & Contrast Media (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amag Pharmaceuticals
2.1.1 Amag Pharmaceuticals Details
2.1.2 Amag Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amag Pharmaceuticals SWOT Analysis
2.1.4 Amag Pharmaceuticals Product and Services
2.1.5 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mallinckrodt SWOT Analysis
2.2.4 Mallinckrodt Product and Services
2.2.5 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Daiichi Sankyo SWOT Analysis
2.3.4 Daiichi Sankyo Product and Services
2.3.5 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Healthcare
2.4.1 Bayer Healthcare Details
2.4.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Healthcare SWOT Analysis
2.4.4 Bayer Healthcare Product and Services
2.4.5 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lantheus
2.5.1 Lantheus Details
2.5.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Lantheus SWOT Analysis
2.5.4 Lantheus Product and Services
2.5.5 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bracco Imaging
2.6.1 Bracco Imaging Details
2.6.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bracco Imaging SWOT Analysis
2.6.4 Bracco Imaging Product and Services
2.6.5 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nordion SWOT Analysis
2.7.4 Nordion Product and Services
2.7.5 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.8 Guerbet
2.8.1 Guerbet Details
2.8.2 Guerbet Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Guerbet SWOT Analysis
2.8.4 Guerbet Product and Services
2.8.5 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.9 GE Healthcare
2.9.1 GE Healthcare Details
2.9.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GE Healthcare SWOT Analysis
2.9.4 GE Healthcare Product and Services
2.9.5 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.10 Medtronic
2.10.1 Medtronic Details
2.10.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Medtronic SWOT Analysis
2.10.4 Medtronic Product and Services
2.10.5 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
3.2.2 Top 10 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Regions
4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
5.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
5.2 USA Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
6.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
6.2 Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.3 UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.4 France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
7.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
7.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.5 India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
8 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
8.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
8.2 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnostic Radiopharmaceuticals & Contrast Media by Countries
9.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Type (2019-2024)
10.3 Radiopharmaceuticals Revenue Growth Rate (2015-2025)
10.4 Contrast Media Revenue Growth Rate (2015-2025)
11 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Segment by Application
11.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2015-2020)
11.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Application (2019-2024)
11.3 Diagnostic Revenue Growth (2015-2020)
11.4 Therapeutic Revenue Growth (2015-2020)
11.5 Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)
11.6 Non-Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)
12 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)
12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)
12.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Regions (2021-2025)
12.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.6 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amag Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 7. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 8. Amag Pharmaceuticals SWOT Analysis
Table 9. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 10. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mallinckrodt Corporate Information, Location and Competitors
Table 12. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 13. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2018-2019)
Table 14. Mallinckrodt SWOT Analysis
Table 15. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 16. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Daiichi Sankyo Corporate Information, Location and Competitors
Table 18. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 19. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 20. Daiichi Sankyo SWOT Analysis
Table 21. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 22. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Healthcare Corporate Information, Location and Competitors
Table 24. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 25. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 26. Bayer Healthcare SWOT Analysis
Table 27. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 28. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Lantheus Corporate Information, Location and Competitors
Table 30. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 31. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 32. Lantheus SWOT Analysis
Table 33. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 34. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bracco Imaging Corporate Information, Location and Competitors
Table 36. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 37. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 38. Bracco Imaging SWOT Analysis
Table 39. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 40. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Nordion Corporate Information, Location and Competitors
Table 42. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 43. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 44. Nordion SWOT Analysis
Table 45. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 46. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Guerbet Corporate Information, Location and Competitors
Table 48. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 49. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 50. Guerbet SWOT Analysis
Table 51. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 52. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GE Healthcare Corporate Information, Location and Competitors
Table 54. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 55. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 56. GE Healthcare SWOT Analysis
Table 57. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 58. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Medtronic Corporate Information, Location and Competitors
Table 60. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 61. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 62. Medtronic SWOT Analysis
Table 63. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 64. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Players (2015-2020)
Table 66. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Players (2015-2020)
Table 67. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions (2015-2020)
Table 69. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
Table 70. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 71. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
Table 74. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Type (2015-2020)
Table 78. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2015-2020)
Table 79. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2021-2025)
Table 80. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2015-2020)
Table 81. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2015-2020)
Table 82. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2021-2025)
Table 83. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Picture
Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type in 2019
Figure 3. Radiopharmaceuticals Picture
Figure 4. Contrast Media Picture
Figure 5. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application in 2019
Figure 6. Diagnostic Picture
Figure 7. Therapeutic Picture
Figure 8. Ionizing Radiation based Radioimaging Picture
Figure 9. Non-Ionizing Radiation based Radioimaging Picture
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share in 2019
Figure 19. Global Top 10 Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions (2015-2020)
Figure 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions in 2018
Figure 24. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 25. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 27. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 29. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 30. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 31. USA Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 32. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 34. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 36. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 37. UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 38. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 39. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 40. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 43. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 44. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 45. Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 46. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 48. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 49. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 50. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 55. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 58. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2015-2020)
Figure 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type in 2019
Figure 60. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Type (2021-2025)
Figure 61. Global Radiopharmaceuticals Revenue Growth Rate (2015-2020)
Figure 62. Global Contrast Media Revenue Growth Rate (2015-2020)
Figure 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2015-2020)
Figure 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application in 2019
Figure 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Application (2021-2025)
Figure 66. Global Diagnostic Revenue Growth Rate (2015-2020)
Figure 67. Global Therapeutic Revenue Growth Rate (2015-2020)
Figure 68. Global Ionizing Radiation based Radioimaging Revenue Growth Rate (2015-2020)
Figure 69. Global Non-Ionizing Radiation based Radioimaging Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 74. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 76. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

  • Stress Management Industry: Global Trends
    Published: 20-Feb-2020        Price: US 5500 Onwards        Pages: 134
    Report Scope: The report offers an exhaustive description and evaluation of the global stress management market. It provides in-depth qualitative and quantitative insights into the report, which aligns with the goals and objectives of our intended customers. The projections are verified through intensive primary and secondary research. The report will enable clients to obtain investment in the stress management industry on the basis of the current business scenario, trends and fut......
  • Global Surgical Waste Management Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 19-Feb-2020        Price: US 3200 Onwards        Pages: 193
    In this report, we analyze the Surgical Waste Management industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also......
  • Global Surgical Overalls Market Data Survey Report 2015-2025
    Published: 17-Feb-2020        Price: US 1500 Onwards        Pages: 60
    Summary The global Surgical Overalls market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, s......
  • Latest Development, Product Innovations and Treatments for Diabetes
    Published: 14-Feb-2020        Price: US 5500 Onwards        Pages: 237
    Report Scope: The key objectives of this study are to - Review the impact that diabetes is having on global health. This includes - - Review of diabetes as a disease. - Review of the epidemiology of diabetes. - Data and statistics by region. - Predictions of future incidence and prevalence of diabetes globally and by region. - Review of the impact that diabetes has and will have in the future. - Review of the current produ......
  • Global Nurse Call Systems (NCS) Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 14-Feb-2020        Price: US 2980 Onwards        Pages: 87
    Snapshot The global Nurse Call Systems (NCS) market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Nurse Call Systems (NCS) by product, region and application, in addition, this report introduces market competition situation among the vendor......
  • Global Poultry Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Feb-2020        Price: US 3480 Onwards        Pages: 109
    Market Overview The global Poultry Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Poultry Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, ......
  • Global Fertility Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Fertility Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fertility Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis......
  • Global Respiratory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Feb-2020        Price: US 3480 Onwards        Pages: 133
    Market Overview The global Respiratory Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales anal......
  • Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 13-Feb-2020        Price: US 3480 Onwards        Pages: 107
    Market Overview The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9594.6 million by 2025, from USD 8567.7 million in 2019. The Diagnostic Radiopharmaceuticals & Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, se......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs